Biologic Therapy Is Not Associated with Increased COVID-19 Severity in Patients with Hidradenitis Suppurativa: Updated Findings from the Global Hidradenitis Suppurativa COVID-19 Registry

Dermatology. 2023;239(2):283-286. doi: 10.1159/000527401. Epub 2022 Dec 23.
No abstract available

MeSH terms

  • Biological Therapy
  • COVID-19*
  • Hidradenitis Suppurativa* / complications
  • Hidradenitis Suppurativa* / drug therapy
  • Humans
  • Registries
  • Severity of Illness Index